Search Results - "Canfell, Karen"

Towards the global elimination of cervical cancer by Canfell, Karen

“…Two very effective prevention strategies for cervical cancer exist – vaccination against the human papillomavirus (HPV) and cervical screening with primary HPV…”
Get full text

Anal cancer in high-income countries: Increasing burden of disease by Kang, Yoon-Jung, Smith, Megan, Canfell, Karen

“…Previous studies have reported that anal cancer incidence has increased in individual countries; however, age-specific trends were not examined in detail. This…”
Get full text

The IARC Perspective on Cervical Cancer Screening by Bouvard, Véronique, Wentzensen, Nicolas, Mackie, Anne, Berkhof, Johannes, Brotherton, Julia, Giorgi-Rossi, Paolo, Kupets, Rachel, Smith, Robert, Arrossi, Silvina, Bendahhou, Karima, Canfell, Karen, Chirenje, Z. Mike, Chung, Michael H, del Pino, Marta, de Sanjosé, Silvia, Elfström, Miriam, Franco, Eduardo L, Hamashima, Chisato, Hamers, Françoise F, Herrington, C. Simon, Murillo, Raúl, Sangrajrang, Suleeporn, Sankaranarayanan, Rengaswamy, Saraiya, Mona, Schiffman, Mark, Zhao, Fanghui, Arbyn, Marc, Prendiville, Walter, Indave Ruiz, Blanca I, Mosquera-Metcalfe, Isabel, Lauby-Secretan, Béatrice

“…This article reviews recent evidence from the International Agency for Research on Cancer on the best methods of screening for cervical cancer, including by…”
Get full text

Cancer care disruption and reorganisation during the COVID-19 pandemic in Australia: A patient, carer and healthcare worker perspective by Edge, Rhiannon, Meyers, Josh, Tiernan, Gabriella, Li, Zhicheng, Schiavuzzi, Alexandra, Chan, Priscilla, Vassallo, Amy, Morrow, April, Mazariego, Carolyn, Wakefield, Claire E, Canfell, Karen, Taylor, Natalie

“…The COVID-19 pandemic has dramatically impacted cancer care worldwide. Disruptions have been seen across all facets of care. While the long-term impact of…”
Get full text

2020 list of human papillomavirus assays suitable for primary cervical cancer screening by Arbyn, Marc, Simon, Marie, Peeters, Eliana, Xu, Lan, Meijer, Chris J.L.M., Berkhof, Johannes, Cuschieri, Kate, Bonde, Jesper, Ostrbenk Vanlencak, Anja, Zhao, Fang-Hui, Rezhake, Remila, Gultekin, Murat, Dillner, Joakim, de Sanjosé, Silvia, Canfell, Karen, Hillemanns, Peter, Almonte, Maribel, Wentzensen, Nicolas, Poljak, Mario

“…Only clinically validated HPV assays can be accepted in cervical cancer screening. To update the list of high-risk HPV assays that fulfil the 2009…”
Get full text

Vulvar cancer in high‐income countries: Increasing burden of disease by Kang, Yoon‐Jung, Smith, Megan, Barlow, Ellen, Coffey, Kate, Hacker, Neville, Canfell, Karen

“…The aim of this study was to assess trends in the age‐specific incidence of vulvar cancer in 13 high‐income countries satisfying a priori conditions regarding…”
Get full text

Disability, psychological distress and quality of life in relation to cancer diagnosis and cancer type: population-based Australian study of 22,505 cancer survivors and 244,000 people without cancer by Joshy, Grace, Thandrayen, Joanne, Koczwara, Bogda, Butow, Phyllis, Laidsaar-Powell, Rebekah, Rankin, Nicole, Canfell, Karen, Stubbs, John, Grogan, Paul, Bailey, Louise, Yazidjoglou, Amelia, Banks, Emily

“…Improved survival means that cancer is increasingly becoming a chronic disease. Understanding and improving functional outcomes are critical to optimising…”
Get full text

A scoping review and meta-analysis on the prevalence of pan-tumour biomarkers (dMMR, MSI, high TMB) in different solid tumours by Kang, Yoon-Jung, O’Haire, Sophie, Franchini, Fanny, IJzerman, Maarten, Zalcberg, John, Macrae, Finlay, Canfell, Karen, Steinberg, Julia

“…Immune checkpoint inhibitors have been approved in the USA for tumours exhibiting mismatch repair deficiency (dMMR), microsatellite instability (MSI), or high…”
Get full text

The projected timeframe until cervical cancer elimination in Australia: a modelling study by Hall, Michaela T, Simms, Kate T, Lew, Jie-Bin, Smith, Megan A, Brotherton, Julia ML, Saville, Marion, Frazer, Ian H, Canfell, Karen

“…In 2007, Australia was one of the first countries to introduce a national human papillomavirus (HPV) vaccination programme, and it has since achieved high…”
Get full text

How has COVID-19 impacted cancer screening? Adaptation of services and the future outlook in Australia by Feletto, Eleonora, Grogan, Paul, Nickson, Carolyn, Smith, Megan, Canfell, Karen

“…The coronavirus disease 2019 (COVID-19) pandemic has caused major disruptions to many aspects of life in Australia and globally. This includes actual and…”
Get full text

Reflecting on the '45 and Up Study' after 15 years: learnings, impact and future opportunities from a large-scale cohort study by McNamara, Martin, Canfell, Karen

Get full text

Health services costs for cancer care in Australia: Estimates from the 45 and Up Study by Goldsbury, David E, Yap, Sarsha, Weber, Marianne F, Veerman, Lennert, Rankin, Nicole, Banks, Emily, Canfell, Karen, O'Connell, Dianne L

“…Cancer care represents a substantial and rapidly rising healthcare cost in Australia. Our aim was to provide accurate population-based estimates of the health…”
Get full text

Systematic review of NTRK 1/2/3 fusion prevalence pan-cancer and across solid tumours by O’Haire, Sophie, Franchini, Fanny, Kang, Yoon-Jung, Steinberg, Julia, Canfell, Karen, Desai, Jayesh, Fox, Stephen, IJzerman, Maarten

“…NTRK gene fusions are rare somatic mutations found across cancer types with promising targeted therapies emerging. Healthcare systems face significant…”
Get full text

The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds by C Kitchener, Henry, Canfell, Karen, Gilham, Clare, Sargent, Alexandra, Roberts, Chris, Desai, Mina, Peto, Julian

“…The ARTISTIC (A Randomised Trial In Screening To Improve Cytology) trial originally reported after two rounds of primary cervical screening with human…”
Get full text

Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis by Kim, Jane J, Simms, Kate T, Killen, James, Smith, Megan A, Burger, Emily A, Sy, Stephen, Regan, Catherine, Canfell, Karen

“…A nonavalent human papillomavirus (HPV) vaccine has been licensed for use in women and men up to age 45 years in the United States. The cost-effectiveness of…”
Get full text

Menopausal hormone therapy: Characterising users in an Australian national cross-sectional study by Velentzis, Louiza S, Egger, Sam, Banks, Emily, Canfell, Karen

“…Menopausal hormone therapy (MHT) is effective for menopausal symptoms, however, its use is also associated with risks of serious health conditions including…”
Get full text

Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models by Brisson, Marc, Bénard, Élodie, Drolet, Mélanie, Bogaards, Johannes A, Baussano, Iacopo, Vänskä, Simopekka, Jit, Mark, Boily, Marie-Claude, Smith, Megan A, Berkhof, Johannes, Canfell, Karen, Chesson, Harrell W, Burger, Emily A, Choi, Yoon H, De Blasio, Birgitte Freiesleben, De Vlas, Sake J, Guzzetta, Giorgio, Hontelez, Jan A C, Horn, Johannes, Jepsen, Martin R, Kim, Jane J, Lazzarato, Fulvio, Matthijsse, Suzette M, Mikolajczyk, Rafael, Pavelyev, Andrew, Pillsbury, Matthew, Shafer, Leigh Anne, Tully, Stephen P, Turner, Hugo C, Usher, Cara, Walsh, Cathal

“…Modelling studies have been widely used to inform human papillomavirus (HPV) vaccination policy decisions; however, many models exist and it is not known…”
Get full text

Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017-2035: Example from Australia by Hall, Michaela T, Simms, Kate T, Lew, Jie-Bin, Smith, Megan A, Saville, Marion, Canfell, Karen

“…Many countries are transitioning from cytology-based to longer-interval HPV screening. Trials comparing HPV-based screening to cytology report an increase in…”
Get full text

Population-based utility scores for HPV infection and cervical squamous cell carcinoma among Australian Indigenous women by Ju, Xiangqun, Canfell, Karen, Howard, Kirsten, Garvey, Gail, Hedges, Joanne, Smith, Megan, Jamieson, Lisa

“…Objective Working in partnership with Indigenous communities in South Australia, we aimed to develop, pilot test and estimate utility scores for health states…”
Get full text

Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial by Canfell, Karen, Caruana, Michael, Gebski, Val, Darlington-Brown, Jessica, Heley, Stella, Brotherton, Julia, Gertig, Dorota, Jennett, Chloe J, Farnsworth, Annabelle, Tan, Jeffrey, Wrede, C David, Castle, Philip E, Saville, Marion

“…Using primary human papillomavirus (HPV) testing for cervical screening increases detection of high-grade cervical intraepithelial neoplastic lesions and…”
Get full text